UK Set to Legalize Babies With DNA From 3 Parents
By KQED,
KQED Radio [With CGS's Marcy Darnovsky]
| 02. 06. 2015
Download audio (MP3)
After a parliamentary vote earlier this week, the United Kingdom is set to become the first country to legalize making a baby with DNA from three parents. The controversial procedure, which prevents mothers from passing on genetic diseases to their children, involves replacing faulty DNA in a mother's eggs with healthy DNA from a third person. Critics say the procedure raises many ethical questions. But British Prime Minister David Cameron said, "We're not playing God here, we're just making sure that two parents who want a healthy baby can have one." We'll discuss the technology and explore whether the U.S. and other countries may follow Britain's lead.
Host: Mina Kim
Guests:
- Hank Greely, director of the Center for Law and the Biosciences and law professor at Stanford University
- Marcelle Cedars, professor and director of the Division of Reproductive Endocrinology & Infertility at UCSF
- Marcy Darnovsky, executive director of the Center for Genetics and Society
More info:
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...